Home » Newsletters » BioWorld Science

BioWorld Science

May 23, 2011

View Archived Issues

Dutasteride reduces risk of prostate cancer in men with small prostates

Denosumab delays pain interference in patients with CRPC

RespiVent reports new PI3K-delta inhibitors

Canadian researchers present new polypeptide PTEN inhibitors

FDA advisory committee recommends retention of indication for Abbott's Trilipix

S-APP-alpha is a possible biomarker in fragile X syndrome and autism

Gamma-sarcoglycan gene therapy safe in patients with limb girdle muscular dystrophy type 2C

ZIOPHARM Oncology files IND application for phase I Ad-RTS-IL-12 trial in melanoma

GSK prepares novel agents for HCV infection

Spanish researchers disclose new acetylcholinesterase inhibitors

New modulators of metabotropic glutamate mGlu4 receptor claimed

New selective adenosine A2A receptor antagonists patented

FDA clears Repligen's phase I trial of RG-3039 for spinal muscular atrophy

Medivir reports 48-week interim results from ASPIRE phase IIb trial of TMC-435

CHMP recommends conditional marketing authorization of Fampyra

Study of Actelion's prostanoid DP2 receptor antagonist in allergic rhinitis meets primary endpoint

GSK and Human Genome Sciences receive CHMP positive opinion for Benlysta

European Commission approves Eliquis for prevention of VTE after hip or knee replacement

CHMP recommends approval of Vibativ for nosocomial pneumonia caused by MRSA

Pfizer receives FDA approval for Sutent in advanced pancreatic neuroendocrine tumors

Auxilium Pharmaceuticals receives payment after launching Xiapex in Germany

Phase II data disclosed on fulranumab in low back and osteoarthritic pain

EMA committee recommends accelerated approval of Victrelis for hepatitis C genotype 1

PharmaGap's anticancer candidate GAP-107B8 shows improved potency and bioavailability in liposomes

Viralytics receives FDA reply regarding clinical hold on phase II Cavatek trial in melanoma

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...